Proposed Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT)

CMS determined that the evidence of benefit for CT screening for lung cancer is sufficient to permit this as an annual benefit for Medicare and Medicaid recipients in the US.  The availability of such coverage will be limited, however, by the need to have the screening as part of a comprehensive counseling (smoking cessation, etc) visit with qualified physicians or non-physician practitioners.  Radiologists and imaging centers must meet specific criteria, and activity must be submitted to a registry.